The Drug Enforcement Administration has announced its intent to publish temporary orders to place the following synthetic opioids, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, in Schedule 1 of the Controlled Substances Act.
- O-desmethyltramadol (other names: ODSMT; desmetramadol; 3-[(1R,2R)-2-[(dimethylamino)methyl]-1-hydroxycyclohexyl]phenol)
- 1-(1-(1-(4-bromophenyl)ethyl)piperidin-4-yl)-5,6-dichloro-1,3-dihydro-2H-benzo[d]imidazol-2-one (commonly known as 5,6-dichloro brorphine or SR-14968)
- 5,6-dichloro-1-(1-(4-chlorobenzyl)piperidin-4-yl)-1,3-dihydro-2Hbenzo[d]imidazol-2-one (commonly known as 5,6-dichloro desmethylchlorphine or SR-17018)
- 3-(3-(1-(1-(4-chlorophenyl)ethyl)piperidin-4-yl)-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-
yl)propanenitrile (commonly known as N-propionitrile chlorphine or cychlorphine)
- 8-(1-(4-chlorophenyl)ethyl)-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one (commonly known as
spirochlorphine or R-6890)
When they are issued these orders will impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (import, export, manufacture, distribute, reverse distribute, engage in research or conduct instructional activities or chemical analysis with, or possess) or propose to handle these substances.
Copyright © 2026 Sandler, Travis & Rosenberg, P.A.; WorldTrade Interactive, Inc. All rights reserved.